NovaBridge Biosciences (NBP) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.00x

NovaBridge Biosciences (NBP) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting $41.00 (capex $41.00 ) from operating cash flow of $13.15 Million. Explore NovaBridge Biosciences (NBP) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$41.00
Capex + Investments

Operating Cash Flow

$13.15 Million
USD

Capital Expenditures

$41.00
USD

NovaBridge Biosciences Cash Flow Reinvestment Rate (2020–2020)

Historical reinvestment intensity for NovaBridge Biosciences across 1 annual periods. Also explore NBP asset base for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for NovaBridge Biosciences (2020–2020)

Year-by-year capital reinvestment analysis for NovaBridge Biosciences. For live market cap and broader valuation context, see market value of NovaBridge Biosciences.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2020 0.02x $8.01 Million $433.56 Million $8.01 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow